| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10886000 | Drug Discovery Today | 2015 | 12 Pages |
Abstract
- PET and MRI play a pivotal role in the development of therapeutic strategies for glioma.
- Preclinical PET/MRI has the potential to be central to the future of drug development for glioma.
- PET/MRI allows simultaneous imaging of therapeutic platforms and multiple aspects of cancer.
- PET/MRI could affect a paradigm shift in the drug development process.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Simon Puttick, Christopher Bell, Nicholas Dowson, Stephen Rose, Michael Fay,